Uniphar (LON:UPR) Hits New 52-Week Low – What’s Next?

Uniphar plc (LON:UPR) shares hit a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 166 ($2.07) and last traded at GBX 166 ($2.07), with a volume of 6471 shares changing hands. The stock had previously closed at GBX 169 ($2.11).

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 310 ($3.87) price target on shares of Uniphar in a report on Wednesday, September 4th.

Uniphar Price Performance

The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.43. The firm has a market cap of £453.21 million, a P/E ratio of 1,185.71 and a beta of 0.75. The business has a 50-day moving average of GBX 186.67 and a two-hundred day moving average of GBX 206.39.

About Uniphar

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.